Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis Juan Francisco Navarro-González, Alberto Ortiz, Ana Cebrián Cuenca, Lluís Segú, Belén Pimentel, Unai Aranda, Blanca Lopez-Chicheri, Margarita Capel, Elisenda Pomares Mallol, Christian Caudron, Juan José García Sánchez, Roberto Alcázar Arroyo

Economic evaluation of haemodialysis. Analysis of cost components based on patient-specific data Lorenzo, Perestelo, Barroso, Torres, Nazco

Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease José J. Ribés-Cruz, Isidro Torregrosa-Maicas, Carmela Ramos-Tomás, Miguel A. Solís-Salguero, M. José Puchades-Montesa, Miguel A. González-Rico, Isabel Juan-García, Patricia Tomás-Simó, Sandra Tejedor-Alonso, Patricia Zambrano-Esteves, Alfonso Miguel-Carrasco